| A Phase 2b, Study of Linsitinib in Subjects With Active, Moderate to Severe Thyroid Eye Disease (TED) (NCT05276063) | Sling Therapeutics, Inc. | 2022-07-01 |
| Hydroxychloroquine in Mild Graves' Orbitopathy (NCT05126147) | National Taiwan University Hospital | 2022-03-21 |
| Supramaximal Rectus Recession for Strabismus in Grave's Ophthalmopathy (NCT04927468) | Sun Yat-sen University | 2021-07-01 |
| The Effect of Teprotumumab on Thyroid Eye Disease and Thyroid Dysfunction (NCT06275373) | Walter Reed National Military Medical Center | 2021-05-12 |
| Sirolimus in Graves' Orbitopathy (NCT05345119) | University of Pisa | 2020-01-15 |
| Tocilizumab in Active Moderate-severe Graves' Orbitopathy (NCT04876534) | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | 2019-12-18 |
| Exploring Immunological Markers Associated With Mental Fatigue in Graves' Disease (NCT05678374) | Vastra Gotaland Region | 2019-10-01 |
| Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO) (NCT03922321) | Immunovant Sciences GmbH | 2019-04-22 |
| Anti-insulin-like Growth Factor-1 Receptor (IGF-1R) Antibodies in Graves' Disease and Graves' Orbitopathy (NCT03498417) | University of Pisa | 2018-06-20 |
| Treatment of Graves´ophthalmopathy with Simvastatin (GO-S) (NCT03131726) | Lund University | 2018-01-26 |
| Bimatoprost as a Treatment for Graves' Orbitopathy (NCT03708627) | Johns Hopkins University | 2017-11-01 |
| Comparison of the Effectiveness of Two Glucocorticoid Regimens for Treatment of Graves' Orbitopathy (NCT05793359) | Medical University of Sofia | 2017-07-25 |
| Therapeutic Efficacy of Orbital Radiotherapy in Patients With Graves' Orbitopathy (NCT05775185) | Medical University of Sofia | 2017-07-25 |
| Glucocorticoids and Bone in Graves' Ophthalmopathy (NCT03122847) | Torben Harsløf | 2017-06-07 |
| Total Thyroidectomy Versus Thionamides in Patients With Moderate-to-Severe Graves' Ophthalmopathy (NCT03066076) | Medical University of Vienna | 2017-03-01 |
| Graves' Orbitopathy and Hypercholesterolemia (NCT02721992) | University of Pisa | 2016-01-01 |
| Analysis Between the Results of Two Surgical Techniques of Orbital Decompression in Patients With Graves Orbitopathy (NCT03278964) | University of Sao Paulo General Hospital | 2015-02-05 |
| Combined Radiotherapy and Intravenous Steroids for Early Progressive Thyroid Eye Disease (NCT02339142) | University of British Columbia | 2015-01-01 |
| Observing the Relationship of Fibroblast Growth Factor and Fibroblast in Thyroid Eye Disease (NCT03324022) | National Taiwan University Hospital | 2014-12-25 |
| Prostaglandin F2-alpha Eye Drops in Thyroid Eye Disease (Bima Study) (NCT02059655) | Cardiff University | 2014-11-01 |
| Doxycycline Treatment in Mild Thyroid-Associated Ophthalmopathy (NCT02203682) | Sun Yat-sen University | 2014-07-01 |
| Retinal Oxygen Saturation in Patients With Graves' Ophthalmopathy and in Normal People (NCT02290704) | Sun Yat-sen University | 2014-01-01 |
| Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy (NCT01727973) | Sun Yat-sen University | 2012-10-01 |
| Comparison Study Between Two Techniques for Correction of Upper Lid Retraction in Patients With Grave's Orbitopathy (NCT01999790) | University of Sao Paulo | 2012-03-01 |
| Tocilizumab Treatment in Graves´ Ophthalmopathy (Graves´ Orbitopathy or Thyroid Eye Disease) (NCT01297699) | Hospital Clinico Universitario de Santiago | 2012-03-01 |
| Liver Function After Intravenous Methylprednisolone Administration (NCT03667157) | Medical University of Warsaw | 2012-01-01 |
| Use of Azithromycin as Immunomodulatory Therapy in Grave&Apos;s Orbitopathy (NCT01379196) | Rabin Medical Center | 2011-05-01 |
| Heart Rhythm After Intravenous Methylprednisolone Administration (NCT04391439) | Medical University of Warsaw | 2011-01-01 |
| Coagulation After Intravenous Methylprednisolone Administration (NCT03535090) | Piotr Miskiewicz | 2011-01-01 |
| Impact of Intravenous Methylprednisolone Treatment on Blood Pressure (NCT03590080) | Medical University of Warsaw | 2011-01-01 |
| Use of Botox in the Management of Thyroid Related Upper Eyelid Retraction (NCT01272414) | University of Toronto | 2011-01-01 |
| A Safety and Tolerability Study of Otelixizumab in Thyroid Eye Disease (NCT01114503) | GlaxoSmithKline | 2010-07-07 |
| A Prospective, Randomized Trial of Intravenous Pulse Versus Sequential Steroid Therapy for Patients With Graves' Orbitopathy (NCT01969019) | Ruijin Hospital | 2010-01-01 |
| The Effect of Early Total Thyroidectomy in the Course of Graves' Orbitopathy (NCT01056419) | Ankara University | 2009-01-01 |
| Bromocriptine and Pentoxifylline in Ophthalmopathy Autoimmune Treatment (NCT01893450) | Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran | 2008-06-01 |
| Color Doppler Imaging of Orbital Venous Flow in Grave's Orbitopathy (NCT00697528) | University of Sao Paulo | 2007-01-01 |
| The Role of TSH Receptor, PPAR-r, IGF-1R, IGF and Cytokines in Different Stages of Graves'Ophthalmopathy (NCT00174057) | National Taiwan University Hospital | 2005-08-01 |
| Thyroid-Associated Ophthalmopathy Subtypes and Orbital Antibodies (NCT00430547) | Barwon Health | 2003-08-01 |
| Thyroid Treatment Trial (NCT00348413) | Singapore National Eye Centre | 2003-06-01 |